LAG-3, TIM-3, and TIGIT: Distinct functions in immune regulation

N Joller, AC Anderson, VK Kuchroo - Immunity, 2024 - cell.com
Summary LAG-3, TIM-3, and TIGIT comprise the next generation of immune checkpoint
receptors being harnessed in the clinic. Although initially studied for their roles in restraining …

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment

D Hanahan, O Michielin, MJ Pittet - Nature Reviews Cancer, 2024 - nature.com
Tumorigenesis embodies the formation of a heterotypic tumour microenvironment (TME)
that, among its many functions, enables the evasion of T cell-mediated immune responses …

Engineering an organic nanoplatform for augmented pyroeletroimmunotherapy

X Li, ML Gao, SS Wang, YL Li, TN Liu… - Advanced …, 2024 - Wiley Online Library
Photothermal immunotherapy has shown great promise in the treatment of tumor metastasis.
However, the thermal resistance of tumor cells substantially compromises the treatment …

[HTML][HTML] Liver X receptor unlinks intestinal regeneration and tumorigenesis

S Das, SM Parigi, X Luo, J Fransson, BC Kern… - Nature, 2024 - nature.com
Uncontrolled regeneration leads to neoplastic transformation,–. The intestinal epithelium
requires precise regulation during continuous homeostatic and damage-induced tissue …

A pan-cancer single-cell RNA-seq atlas of intratumoral B cells

E Fitzsimons, D Qian, A Enica, K Thakkar, M Augustine… - Cancer Cell, 2024 - cell.com
Tumor-infiltrating B cells play a significant role in tumor development, progression, and
prognosis, yet a comprehensive classification system is lacking. To address this gap, we …

Distinct soluble immune checkpoint profiles characterize COVID-19 severity, mortality and SARS-CoV-2 variant infections

TG Paranga, M Pavel-Tanasa… - Frontiers in …, 2024 - frontiersin.org
Introduction Over the past four years, the COVID-19 pandemic has posed serious global
health challenges. The severe form of disease and death resulted from the failure of immune …

Peptide drugs: a new direction in cancer immunotherapy

X Sui, X Niu, X Zhou, Y Gao - Cancer Biology & Medicine, 2023 - pmc.ncbi.nlm.nih.gov
Cancer immunotherapy has emerged as a promising approach in cancer treatment and is
considered a major advancement after surgical interventions, radiotherapy, chemotherapy …

Consensus, debate, and prospective on pancreatic cancer treatments

J Wang, J Yang, A Narang, J He, C Wolfgang… - Journal of Hematology & …, 2024 - Springer
Pancreatic cancer remains one of the most aggressive solid tumors. As a systemic disease,
despite the improvement of multi-modality treatment strategies, the prognosis of pancreatic …

Immunomodulation in non-alcoholic fatty liver disease: exploring mechanisms and applications

Z Guo, Q Wu, P Xie, J Wang, W Lv - Frontiers in Immunology, 2024 - frontiersin.org
Non-alcoholic fatty liver disease (NAFLD) exhibits increased lipid enrichment in
hepatocytes. The spectrum of this disease includes stages such as nonalcoholic simple fatty …

Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis

BK Nirala, T Yamamichi, DI Petrescu, TN Shafin… - Cancers, 2023 - mdpi.com
Simple Summary Osteosarcoma (OS) is the most common bone tumor in the pediatric
population. Currently, no effective molecularly targeted therapies are available for OS. The …